Pharmafile Logo
Pharmafocus logo
Advanced Search

Study reveals potential link between COVID-19 and Parkinson’s Disease

December 20, 2021
Sales and Marketing

Scientists in The Netherlands have detailed a possible correlation between COVID-19 and the onset of Parkinson’s disease. The findings may …

News

New COVID-19 drug Sotrovimab becomes available on NHS

December 20, 2021
Sales and Marketing

Sotrovimab, commercially known as Xevudy, is now available on the NHS to reduce the risk of vulnerable patients needing hospitalisation …

News

CDC recommends mRNA vaccines over J&J

December 17, 2021
Medical Communications

The CDC has recommended Pfizer-BioNTech and Moderna COVID-19 vaccines over Johnson & Johnson jabs. The recommendation from CDC Director Dr …

News

COVID-19 booster vaccine triggers immune response in days, not weeks, scientists say

December 17, 2021
Medical Communications

COVID-19 booster jabs trigger an immune response in a matter of days, rather than weeks, scientists have shared. Data suggests …

News

NICE recommends offering PrEP to those at high risk of HIV

December 17, 2021
Medical Communications

People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the …

News

Omicron grows 70 times faster than Delta in bronchial tissue

December 16, 2021
Business Services

The COVID-19 variant, Omicron, has been found to replicate around 70 times faster than the original and Delta variants of …

News

Potential drugs for AMD treatment identified using stem-cell based research

December 16, 2021
Business Services

Researchers at the National Institutes of Health (NIH) have identified two drug candidates to slow dry age-related macular degeneration (AMD), …

News

FDA pauses several trials of Merck’s investigational HIV drug

December 16, 2021
Business Services

The FDA has placed holds on several clinical trials for the oral and implant formulations of investigation drug islatravir (MK-8591), …

News

European Commission backs Johnson & Johnson COVID-19 booster for adults

December 16, 2021
Business Services

The EC has recommended a booster dose of Johnson & Johnson’s COVID-19 vaccine at least two months after a first …

News

Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation

December 15, 2021
Research and Development

Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …

News

Bionaut Labs and Candel Therapeutics collaborate to deliver immunotherapies

December 15, 2021
Research and Development

Bionaut Labs, and Candel Therapeutics, have announced a strategic collaboration to investigate the use of Bionaut’s remote-controlled microscale robots for …

News

Positive results in Phase III trial of candidemia and invasive candidiasis

December 15, 2021
Research and Development

Cidara Therapeutics and Mundipharma have announced positive topline data from the ReSTORE Phase III clinical trial, evaluating the efficacy and …

News

Sanofi and GSK announce positive booster data for COVID-19 vaccine candidate

December 15, 2021
Research and Development

Sanofi and GSK have announced positive preliminary booster data for their COVID-19 vaccine candidate, and continuation of their Phase III …

News

European Commission approves Pfizer drug for adults with moderate-to-severe atopic dermatitis

December 14, 2021
Manufacturing and Production

The EC has approved the investigational once-daily Janus kinase 1 (JAK1) inhibitor, abrocitinib, for the treatment of moderate-to-severe atopic dermatitis …

News

India’s Serum Novavax jab to be launched for children in six months

December 14, 2021
Medical Communications

The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six …

News

Phase III trial results gives hope to B-Cell lymphoma patients

December 14, 2021
Manufacturing and Production

Bristol Myers Squibb (BMS) reported that interim assessment data from the Phase III TRANSFORM clinical trial of Breyanzi (lisocabtagene maraleucel; …

News
astrazeneca_plaque

Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy

December 14, 2021
Medical Communications

Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …

News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …

Appointment
credit_-_crevis_shutterstock_340710245_720

CAR-T therapy trials show promise for earlier use in lymphoma

December 13, 2021
Sales and Marketing

Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …

News

New clinical trial testing diabetes drug for reducing risk of Alzheimer’s

December 13, 2021
Sales and Marketing

A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026